- Home
- XRTX vs MGRX Comparison
XRTX vs MGRX Comparison
Compare XRTX & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | MGRX |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.2M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | XRTX | MGRX |
|---|---|---|
| Price | $0.84 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.4K | ★ 378.6K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $392.31 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.35 | $0.18 |
| 52 Week High | $3.60 | $2.28 |
Technical Indicators
Market Signals| Indicator | XRTX | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.30 | 31.17 |
| Support Level | $0.83 | N/A |
| Resistance Level | $1.15 | $0.48 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 21.87 | 22.50 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.